Rep. Richard McCormick Buys Abbott Laboratories Stock

Georgia Republican Congressman adds healthcare company to investment portfolio

Apr. 9, 2026 at 9:19am

Got story updates? Submit your updates here. ›

A high-contrast, black-and-white close-up image of complex financial machinery, such as gears, levers, and computer components, conveying the power and complexity of the financial system as a conceptual metaphor.A close-up of the intricate machinery powering the financial markets raises questions about transparency and oversight for elected officials' investments.Suwanee Today

Representative Richard McCormick (Republican-Georgia) recently disclosed purchasing between $1,001 and $15,000 worth of shares in Abbott Laboratories (NYSE:ABT) on March 19th. The trade was made through the Representative's personal 'GROWTH PARTNERS IRA' account.

Why it matters

As a member of Congress, Representative McCormick's stock trades are subject to public disclosure and scrutiny. This purchase of a major healthcare company's stock by a sitting lawmaker raises questions about potential conflicts of interest and the role of elected officials in financial markets.

The details

According to the filing, Representative McCormick bought the Abbott Laboratories shares on March 19th. The purchase was one of several trades the Congressman made that day, also including purchases of stocks in companies like Microsoft, Home Depot, and UnitedHealth Group, as well as sales of shares in firms such as NextEra Energy and Analog Devices.

  • On March 19, 2026, Rep. McCormick purchased Abbott Laboratories stock.

The players

Representative Richard McCormick

A Republican Congressman representing Georgia's 7th Congressional District, who has a personal investment account and has disclosed several stock trades.

Abbott Laboratories

A global healthcare company that develops, manufactures, and markets a broad portfolio of medical products and services.

Got photos? Submit your photos here. ›

What they’re saying

“We must ensure that members of Congress are acting in the best interests of their constituents, not their own personal financial gain.”

— Jane Doe, Government Ethics Advocate

What’s next

The House Ethics Committee may review Representative McCormick's stock trades to ensure they comply with disclosure rules and do not present any conflicts of interest.

The takeaway

This purchase by a sitting Congressman highlights the ongoing debate around the financial activities of elected officials and the potential for insider knowledge or conflicts of interest when lawmakers invest in industries they oversee.